小村 弘

持続的まちづくりにおける小規模店舗の利用に関する研究—奈良県奈良市の歴史的市街地を対象に 

日本観光学会誌 65 33-42 2024年12月31日  

歴史的市街地である「ならまち」の再生 : カフェ、雑貨店、飲食店の出店と町家の利用—Regeneration of Nara-machi, A historical urban area : Opening of cafes, Zakka stores, restaurants and usage of Machiya 

日本観光学会誌 = Journal of tourism research (64) 42-49 2023年12月  

The Trends and Future Prospective of In Silico Models from the Viewpoint of ADME Evaluation in Drug Discovery. 

Pharmaceutics 15(11) 2023年11月12日  

DruMAP: A Novel Drug Metabolism and Pharmacokinetics Analysis Platform. 

Journal of medicinal chemistry 66(14) 9697-9709 2023年7月27日  

歴史・文化資源を有する市街地における再構築について : ならまち、松江市及び金沢市の老舗による場の創出を中心として—Utilization of Historical and Cultural Resources in Historic Urban Areas and Reconstruction of Towns : Creation of Cultural Experience Places by Long-established Companies in Nara-machi, Kanazawa and Matsue 

日本観光学会誌 = Journal of tourism research (63) 73-82 2022年12月  

Utilizing public and private sector data to build better machine learning models for the prediction of pharmacokinetic parameters. 

Drug discovery today 27(11) 103339-103339 2022年11月  

A public-private partnership to enrich the development of in silico predictive models for pharmacokinetic and cardiotoxic properties. 

Drug discovery today 26(5) 1275-1283 2021年5月  

Development of an In Silico Prediction Model for P-glycoprotein Efflux Potential in Brain Capillary Endothelial Cells toward the Prediction of Brain Penetration. 

Journal of medicinal chemistry 64(5) 2725-2738 2021年3月11日  

歴史的市街地であるならまち再生の変遷 ─まち再生における老舗の役割を中心に─ 

日本観光学会誌 61 1-12 2020年  

Constructing an In Silico Three-Class Predictor of Human Intestinal Absorption With Caco-2 Permeability and Dried-DMSO Solubility. 

Journal of pharmaceutical sciences 108(11) 3630-3639 2019年11月  

Prediction of Hepatic Clearance of Stereoselective Metabolism of Carvedilol in Liver Microsomes and Hepatocytes of Sprague-Dawley and Cytochrome P450 2D-Deficient Dark Agouti Rats. 

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 22(1) 72-84 2019年  

Pharmacokinetics and disposition of dalcetrapib in rats and monkeys. 

Xenobiotica; the fate of foreign compounds in biological systems 44(12) 1117-26 2014年12月  

Characterization of gastrointestinal absorption of digoxin involving influx and efflux transporter in rats: application of mdr1a knockout (-/-) rats into absorption study of multiple transporter substrate. 

Xenobiotica; the fate of foreign compounds in biological systems 44(11) 1039-45 2014年11月  

Application of a physiologically based pharmacokinetic model informed by a top-down approach for the prediction of pharmacokinetics in chronic kidney disease patients. 

The AAPS journal 16(5) 1018-28 2014年9月  

Development of a hybrid physiologically based pharmacokinetic model with drug-specific scaling factors in rat to improve prediction of human pharmacokinetics. 

Journal of pharmaceutical sciences 102(11) 4193-204 2013年11月  

Application of hybrid approach based on empirical and physiological concept for predicting pharmacokinetics in humans--usefulness of exponent on prospective evaluation of predictability. 

Drug metabolism and disposition: the biological fate of chemicals 41(2) 498-507 2013年2月  

In vitro and in vivo small intestinal metabolism of CYP3A and UGT substrates in preclinical animals species and humans: species differences. 

Drug metabolism reviews 43(4) 476-98 2011年11月  

Comparative assessment of empirical and physiological approaches on predicting human clearances. 

Journal of pharmaceutical sciences 100(3) 1147-55 2011年3月  

Species differences in in vitro and in vivo small intestinal metabolism of CYP3A substrates. 

Journal of pharmaceutical sciences 97(5) 1775-800 2008年5月  

Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4. 

European journal of pharmacology 559(2-3) 202-9 2007年3月22日